These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 38687080

  • 1. Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan.
    Uwamino Y, Aoki W, Inose R, Kamoshita Y, Mikita K, Namkoong H, Nishimura T, Matsushita H, Hasegawa N.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0021824. PubMed ID: 38687080
    [Abstract] [Full Text] [Related]

  • 2. Difference in drug susceptibility distribution and clinical characteristics between Mycobacterium avium and Mycobacterium intracellulare lung diseases in Shanghai, China.
    Wang W, Yang J, Wu X, Wan B, Wang H, Yu F, Guo Y.
    J Med Microbiol; 2021 May 04; 70(5):. PubMed ID: 33999797
    [Abstract] [Full Text] [Related]

  • 3. A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes.
    Aoki A, Jinno H, Ogawa K, Nakagawa T, Inagaki T, Wajima T, Okamoto Y, Uchiya KI.
    Microbiol Spectr; 2023 Feb 14; 11(1):e0432622. PubMed ID: 36622171
    [Abstract] [Full Text] [Related]

  • 4. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T, Matsui H, Hirose T, Suzuki J, Saito M, Akaba T, Kobayashi K, Akashi S, Kawashima M, Tamura A, Nagai H, Akagawa S, Kobayashi N, Ohta K.
    BMC Infect Dis; 2016 Jan 27; 16():31. PubMed ID: 26818764
    [Abstract] [Full Text] [Related]

  • 5. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y, Yoshida K, Miyashita N, Niki Y, Oka M.
    J Infect Chemother; 2006 Aug 27; 12(4):195-202. PubMed ID: 16944258
    [Abstract] [Full Text] [Related]

  • 6. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
    Aberg JA, Wong MK, Flamm R, Notario GF, Jacobson MA.
    HIV Clin Trials; 2001 Aug 27; 2(6):453-9. PubMed ID: 11742432
    [Abstract] [Full Text] [Related]

  • 7. Mycobacterium avium strains resistant to clarithromycin and azithromycin.
    Heifets L, Mor N, Vanderkolk J.
    Antimicrob Agents Chemother; 1993 Nov 27; 37(11):2364-70. PubMed ID: 8031351
    [Abstract] [Full Text] [Related]

  • 8. Minimum inhibitory concentration distributions for Mycobacterium avium complex-towards evidence-based susceptibility breakpoints.
    Schön T, Chryssanthou E.
    Int J Infect Dis; 2017 Feb 27; 55():122-124. PubMed ID: 28069470
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
    van Ingen J, Egelund EF, Levin A, Totten SE, Boeree MJ, Mouton JW, Aarnoutse RE, Heifets LB, Peloquin CA, Daley CL.
    Am J Respir Crit Care Med; 2012 Sep 15; 186(6):559-65. PubMed ID: 22744719
    [Abstract] [Full Text] [Related]

  • 11. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
    Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, Wilson R, Graviss EA, Wallace RJ.
    Am J Respir Crit Care Med; 2006 Oct 15; 174(8):928-34. PubMed ID: 16858014
    [Abstract] [Full Text] [Related]

  • 12. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD, Talbot JA, Chomyc S, Davison E, Singer J, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG.
    Clin Infect Dis; 1998 Dec 15; 27(6):1401-5. PubMed ID: 9868650
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC, Wu MF, Chen HC, Huang WC.
    J Microbiol Immunol Infect; 2018 Oct 15; 51(5):636-643. PubMed ID: 28705770
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of potassium tellurite for rapid-drug susceptibility testing of Mycobacterium avium complex.
    Afghani B, Fujiyama D.
    J Investig Med; 2001 May 15; 49(3):292-6. PubMed ID: 11352188
    [Abstract] [Full Text] [Related]

  • 16. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH, Huh HJ, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY.
    J Infect Chemother; 2018 Apr 15; 24(4):315-318. PubMed ID: 29223615
    [Abstract] [Full Text] [Related]

  • 17. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand.
    Sirichoat A, Kaewprasert O, Hinwan Y, Faksri K.
    PLoS One; 2023 Apr 15; 18(11):e0294677. PubMed ID: 37992075
    [Abstract] [Full Text] [Related]

  • 18. [Macrolide and linezolid susceptibility testing for Mycobacterium intracellulare isolates].
    Duan H, Liang Q, Chu N, Huang H.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Apr 15; 37(4):266-9. PubMed ID: 24969714
    [Abstract] [Full Text] [Related]

  • 19. [Clinical features and treatment history of clarithromycin resistance in M. avium-intracellulare complex pulmonary disease patients].
    Kuwabara K, Tsuchiya T.
    Nihon Kokyuki Gakkai Zasshi; 2007 Aug 15; 45(8):587-92. PubMed ID: 17763685
    [Abstract] [Full Text] [Related]

  • 20. The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study.
    Hosono Y, Kitada S, Yano Y, Mori M, Miki K, Miki M, Yoshimura K, Kagawa H, Oshitani Y, Yokota S.
    J Infect Chemother; 2018 May 15; 24(5):353-357. PubMed ID: 29361415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.